Source: Pharmac
What we are doing
We are pleased to announce a listing agreement with B. Braun New Zealand Pty Limited (“B. Braun”) for the supply of needles and syringes products to DHBs.
In summary this will result in:
- B. Braun’s needles and syringes products being listed on the Pharmaceutical Schedule from 1 March 2019 under a national agreement that all DHBs may purchase under (“Agreement”).
This is a non-exclusive listing agreement, DHBs would continue to be able to purchase other suppliers’ brands of needles and syringes products.
Our response to what you told us
We’re really grateful for the time people took to respond to this consultation.
A summary of the main theme raised in feedback and our response to the feedback received, is set out below.
|
Theme |
PHARMAC Staff Comment |
|---|---|
|
Ministry of Health Advising no technical resource impacts anticipated as a result of proposal |
Noted |
If you have any questions about this decision, you can email us at enquiry@pharmac.govt.nz; or call our toll free number (9 am to 5 pm, Monday to Friday) on 0800 66 00 50.
Last updated: 16 January 2019